key: cord-0857378-zy3b2r5j
authors: Salma, Umme
title: Relationship of COVID-19 with Pregnancy
date: 2021-03-22
journal: Taiwan J Obstet Gynecol
DOI: 10.1016/j.tjog.2021.03.005
sha: 2b857eefd0fdd83ecce57bc9113c5067eab89492
doc_id: 857378
cord_uid: zy3b2r5j

COVID-19 a pandemic disease caused by the SARS-CoV2 virus, which has been emerged in Wuhan city China from early December 2019 which subsequently spreading globally. As a consequence of the physiological adaptive changes and immunosuppressive condition during pregnancy are more susceptible to respiratory tract infection and pneumonia that perhaps makes them more at risk to COVID-19. There is scarce information available on COVID-19 pregnancy and no reliable evidence for vertical transmission. It is a concern that newborns are risk from postpartum contamination. Meanwhile, there was no vaccine and specific therapeutic drugs for COVID19. The Multidisciplinary team will manage by close supervision, isolated negative pressure room, and routinely fetal monitoring. The Timing and mode of delivery depend on the critical condition of the mother and fetal. The newborns need a14 days period of precautionary isolation. In the present study, addressed the most recent data on 149 pregnant women and 96 newborns with typical symptoms and planning of management which response to COVID-19 that will help for frontline doctor to the management of COVID-19 associated pregnancy and newborns baby. Repeated testing, contact tracing and self-isolation will assist to control the spread of SARS-CoV2 infection and COVID-19 disease until specific vaccine and pharmaceuticals drugs of COVID-19 are available.

Currently, coronavirus infection 2019 is spreading globally, the World Health Organization (WHO) declares on 11 March 2020 as a pandemic disease [1] . The first outbreak was reveled in Wuhan in the Hubei province of China then spreading rapidly to elsewhere of the world [2] [3] [4] . As of 25 March 2020, COVID-19 has caused more than 420,000 confirmed cases and 18,887 deaths globally, including 81,852 confirmed cases and 3,287 deaths in China [5] . The outbreaks of COVID-19 with pregnancy regards as clinical characteristics and outcomes [6] . In pregnancy, the physiological alter of immunity and a cardiopulmonary system that may disproportionately be affected by any virus causes respiratory illness and an increased rate of morbidity and mortality. Previous, documented the death of pregnant women from the severe acute respiratory syndrome coronavirus (SARS-Co V) and Middle East respiratory syndrome coronavirus [7] [8] [9] [10] . There is no confirmed evidence for intrauterine infection in late pregnancy by vertical transmission. While no available reported on COVID-19 infection in the first trimester, although about vertical transmission there were still no acceptable laboratories and clinical finding to prove it [11] [12] [13] [14] . There is a chance of abortion, delivery, fetal growth restriction, fetal distress, like SARS-CoV-1 infection [11, 15] . The World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) draw on previous knowledge and some specific management of out breaking coronavirus that may be appropriate for COVID -19 pregnant women [16, 17] . Currently, many countries outbreak of COVID-19 in pregnancy, therefore we have to provide exact information of COVID-19 for awareness to the health worker, pregnant women, and the general public. Thus, the present study to review clinical aspects for managing COVID-19 infected pregnant women.

J o u r n a l P r e -p r o o f Pathophysiology COVID-19 as a SARS-CoV-2 belongs to the category of betaCoVs, a subfamily of Coronavirinae consisting of a single-stranded positive-sense ribonucleic acid (RNA). Previously reported all kinds of coronaviruses produced human disease either by bats or rodents [18] . The spike protein surrounded the SARS-CoV-2 to consist variable receptor-binding domain (RBD) and bind to receptor-angiotensin-converting enzyme-2(ACE-2) that available in lungs, heart, kidney and gastrointestinal tract [19] . Therefore COVID-19 patients manifest upper and lower respiratory symptoms. The receptor-binding domain of SARS-CoV-2 shown to be a mutated version of its generally intimately associated virus according to their genomic sequence [20] .

Based on pandemic laboratory trials the pathophysiological mechanism of SARS-CoV-2 are still unidentified, while the similarity of genomic sequence SARS-CoV may provide clarification for the inflammatory reaction that appears as pneumonia [13] . The structure of COVID-19 represents in (Figure1). 

The animal source of SARS-CoV2 and genomic strain closely related to bats [21] . The first COVID-19 patient-related in Wuhan at the seafood wholesale market, and perhaps spread from animal to human, after while many cases existing coronavirus but this theory was failure to support. There was reliable evidence for transmission of COVID-19 from human-to-human [22, 23] . The respiratory droplets and contact spreading is the main pathway for transmission. Few data exist coronavirus may cause complications mainly in the third trimester of pregnancy but may not support the vertical transmission from mother to fetus, while the newborns affected by contamination mother (Figure 2 ). J o u r n a l P r e -p r o o f presented with fever, cough, fatigue approximately number of 30, 24, and 7, while fewer symptoms were loss of appetite 3 and diarrhea 1 respectively [27] . Total of 149 patients with COVID-19 included this study with symptoms such as fever 149, cough 140, fatigue 48, and malaise 29 pregnant women with complications mainly presented in the mid and late gestational weeks [24, 26, 12, [30] [31] [32] [33] [34] [35] [36] . However, it is of note that the outbreaks of COVID-19 virus in early pregnancy are unidentified [14] . The physiology alternation of pulmonary function during pregnancy may risk for COVID-19 that implement the susceptibility and severity of pneumonia. [26, 37, 38] . Clinical characteristic represented in (Table 1) .

The COVID-19 infected pregnant women and who had a travel-related history of COVID-19 need to immediately self-isolate for screening and testing. Currently, there is no confirmation data for either vaccine or any drugs from a clinical trial to effective treatment against COVID- 19. It is strictly to avoid unnecessary moving crowded places, social distancing mandates and avoided close contact. Many women suffered a psychological impact of the outbreaks as well as higher levels of stress, depression, and anxiety which deteriorate to a critical condition. Health professionals ensuring their requirements are addressed and provide resources for psychological support to minimize the critical state of pregnancy. The identified of COVID-19 pregnant women immediately isolated in designated wards in existing hospitals with isolated negative pressure room, adequate health care resource for monitoring mother and fetus, available intensive care unit, the capability of emergency delivery and facility for newborns [39] . Isolation is another main tool for case identification besides nucleic acid testing to prevent potential J o u r n a l P r e -p r o o f outbreaks. The US Centers for Disease Control and Prevention provide supporting evidence to observe 14 days with repeated testing that may reduce precautionary self-isolation [40] . Isolation and testing strategy to ensure early diagnosis and early management of patients, therefore it may consider as a basic component of a combination approach to control COVID-19 and reduce further transmission.

The laboratory findings normal or decrease white blood cells, low lymphocyte, and increased Creactive protein. Many women have experienced mild thrombocytopenia, raise creatine phosphokinase, and liver enzymes in addition to high alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [41] . Routinely analysis of urine and stool has a facility to detect the condition of the virus and shedding of the virus. Currently, the real-time reverse transcription-polymerase chain reaction (RT-PCR) assay used for confirmation of SARS-CoV-2 from throat swab who suspected COVID-19 [42] . United states have build 84 public health laboratories for testing of COVID-19 the specific primers of this test for SARS-CoV-2 to target their envelope, RNA-dependent RNA polymerase (RdRp), and nucleocapsid genes [43] . These detected which RdRp assay has capable the maximum analytical sensitivity. However, using the RT-PCR method to amplification of DNA and viral load in COVID-19 which may likely theoretically explanation. Regarding detecting of COVID-19 from a specimen of the lower respiratory tract has more diagnostic value comparatively upper respiratory tract [44] . WHO preferred a high significance for the detection of COVID-19 from a specimen of the lower respiratory tract such as sputum, endotracheal aspirate, or bronchoalveolar lavage. A specimen of the upper respiratory tract required when asymptomatic of the lower respiratory tract infection or J o u r n a l P r e -p r o o f situation demand. Chest radiograph or CT scan provides essential knowledge for the clinical state of COVID-19 in pregnant [44] [45] [46] [47] .

The tertiary hospitals were better for the isolation with the initial management of COVID-19 infected pregnant women. The health care should be concerns about isolates negative-pressure room for confirm case, and suspected cases only need isolates. The hospitals should exist negative-pressure room in ICU and NICU [48] . All physician and medical staff should be selfprotection by PPE (such as gown, N95 masks, goggles, and gloves) during dealing with patients [49] . There is no confirmed evidence for vaccine and specific antiviral drugs against COVID-19.

The principle treatment for severe COVID-19 infection has symptomatic and oxygen therapy. In addition to mechanical ventilation requires if respiratory failure refractory to oxygen therapy, besides, the management of septic shock by hemodynamic support. Although, no approved antiviral for COVID-19, but may propose several approaches like lopinavir or ritonavir (400/100 mg every 12 hours), chloroquine (500 mg every 12 hours), and hydroxychloroquine (200 mg every 12 hours). Besides, Alpha-interferon (e.g., 5 million units by aerosol inhalation twice per day) has used. However, COVID-19 with pneumonia treated by antibiotics [39] . It is also essential to apply supportive therapies such as the fluid infusion, adequate rest and proper nutritional diet. The management protocol represents a diagram in (Figure 3 

It needs to regular monitoring of fetal heart rate by stereoscope or Doppler with compatible and dependable on gestational weeks, while ultrasound considered a stander method to determine fetal deformity, any intrauterine complication, and fetal death. Close supervision might help to make a decision, to continue a pregnancy or emergency termination and delivery. 

There is no evidence for termination of pregnancy due to COVID-19 infection. Adequate care, proper treatment, and follow-up may continue to term pregnancy. The critical condition of patients will discontinue the pregnancy because of the endangering mother and fetus by emergency delivery on the consent of the patient's family. The clinicians should be selfprotection and know the severity of risk during dealing with labor patients. The time and mode J o u r n a l P r e -p r o o f of delivery are depending on the status of the mother and fetal [57] . Currently, there was no reliable reported for vertical transmission and contraindication of vaginal delivery of COVID-19 patients [12, 54] . The vaginal delivery preferred when labor will progress actively with the spontaneous onset and operative delivery concern to shortening the second stage of labor [58] .

The present study review thirty-three vaginal deliveries without any difficulty, therefore it indicates vaginal delivery is possible for COVID-19 mother. Conversely, for cesarean delivery, the operative room should be confirmed with negative pressure and well ventilation. The surgeon should self-protect with (PPE) during the surgery procedure of COVID-19 patients. Besides, the cesarean section preferred in two cases of COVID-19 pregnant women due to the failure of induction and arrest of the descendent part [41] . Current reported on eleven COVID-19 patients (12 -38 gestational week), among ten patients delivered by cesarean section and one patient by vaginal delivery with no complication or death of newborns. Similar reported to seven patients had CS with good neonatal outcomes except one who had positive SARS-CoV-2 (table1) [25, 37] . Several cases of COVID-19 with pneumonia preferred either emergency or scheduled CS [29, 38, [59] [60] [61] [62] [63] . benefited effects found to use of antibiotic as prophylaxis such as azithromycin, cefoxazole, and cephalosporin before delivery and some of the cases continued after delivery. The antiviral favipiravir drug was also used but the dosage was not mentioned. Above discussion, it was clearly understood that antibiotic along with oseltamivir and ganciclovir were vastly used may provide better outcomes. As well the multidisciplinary team recommended to start of combined antibiotic and antiviral drugs after diagnosis of cases and preferred cesarean delivery that may better improve the condition and avoided the complications of both mother and fetus. Though there was no contraindication of vaginal delivery but limited data available. Perhaps the widely used of this management has may prognosis of maternal and fetal outcomes.

The Present study reviews a total one-hundred forty-nine pregnant women with COVID-19 positive who gave delivery ninety-six newborns among 1 had died due to DIC and multiple organ failure. The Apgar scores of all 95 infants had ≥7 at 1 minute and ≥9 at 5 minutes respectively. The collected of nasopharyngeal swab from all 95 infants for COVID-19 had tested by SARS-Cov2-19 PCR. Four infants had shown COVID-19 positive among 1 had missing information, while 91 had shown COVID-19 negative. To minimize the risk of contact transmission the neonate was isolated whereas other family member and as well as nurses were taken care of them. As well, 10 neonates had breastfeeding with mother using surgical masks.

The one COVID-19 positive neonate had admitted to the specialized design of children's hospital and two neonates admitted into the NICU, after two weeks one infant was discharged home by two consecutive negative nucleic acid tests, while two neonates were improved after ventilation but insufficient information about discharge.

Total six neonate were addressed of some complication after delivery, such as three neonates had fever, cough, 1 had fatigue, 1 had gastrointestinal and respiratory symptoms and 1had slightly decreased responsiveness and muscle tone respectively.

To our knowledge, there was no reliable evidence for SARS-CoV-2 viral detected in conception product, fetus, amniotic fluids, placenta and breastfeeding of COVID-19 pregnant women [14] .

Recent studies reported on two neonates have identified the COVID-19 infection after 36 hours and 17 days of delivery due to postpartum contamination [63] . It is advisable to early umbilical cord clamping and isolates newborns at least 14 days to reduce the viral transmission. Two COVID-19 infected mothers had breastfed without the use of surgical masks, the one newborn was infected, and one has suspected on the first and third day [62] . Newborns with suspected SARSCoV2 need to immediately isolation with a chest CT scan, swab specimens, and nucleic acid test (NAT) [30] . The COVID-19 infected mother suffered hypoxemia that adverse effects on fetal such as birth asphyxia and premature birth. The obstetricians should concern with neonatologist during preparing for resuscitation of a neonate in the delivery room to facilitate the prognosis of the neonate. To ensure the health support to require all facility to suspected newborns.

Pregnant women infected with COVID-19 need to more intensive attention. Currently, there is limited data on COVID-19 with pregnancy and found mostly during late pregnancy which is risks for mother and fetus. During late pregnancy of COVID-19 infected mother may risk of J o u r n a l P r e -p r o o f adverse obstetrical outcomes. A multi-disciplinary team contact should be adopted for dealing with these patients as it allows effectively sharing knowledge and expertise as well as responsibility. However, repeated testing, contact tracing, and self-isolation may control the spread of SARS-CoV2 and COVID-19 infection until specific treatment either by vaccine or drugs are available.

None

Ajay Kumar Mishra. COVID-2019 and pregnancy: A plea for transparent reporting of all cases

A novel coronavirus from patients with pneumonia in China

World Health Organization (WHO)

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Coronaviruses: genome structure, replication, and pathogenesis

Characteristics of and important lessons from the coronavirus disease 2019 (CPVOD-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention

Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome

Middle East respiratory syndrome corona virus (MERS CoV CoV) infection during pregnancy: report of two cases and review of the literature

Isolation of a novel corona virus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus (MERS-CoV)

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Genomic characteristic on and epidemiology of 2019 novel corona virus: implications for virus origins and receptor binding

What are the risks of COVID-19 infection in pregnant women?

A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome

Clinical management of severe acute respiratory infection when Novel coronavirus (2019-nCoV) infection is suspected: Interim Guidance

Interim Considerations for Infection Prevention and Control of Coronavirus Disease 2019 (COVID-19) in Inpatient Obstetric Healthcare Settings

Bat Corona viruses in China

A Novel Corona virus Associated with Severe Acute Respiratory Syndrome

The Proximal Origin of SARS-CoV-2

Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry

Novel wuhan (2019-nCoV) coronavirus

Receptor recognition by novel coronavirus from Wuhan: analysis based on decade-long structural studies of SARS

Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

Under the epidemic situation of COVID-19, should special attention to pregnant women be given

Clinical features of patients infected with 2019 novel corona virus in Wuhan

Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children

Epidemiology, Pathogenesis, and Control of COVID-19

Clinical analysis of 10 neonates born to mothers with 2019nCoV pneumonia

Potential maternal and infant outcomes from (Wuhan) corona virus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human corona virus infections

Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2)

Characteristics of and important lessons from the corona virus disease2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Potential presymptomatic transmission of SARS-CoV-2, Zhejiang province China 2020

Presumed asymptomatic carrier transmission of COVID-19

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis

Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study

Diagnosis and treatment guideline for COVID-19 infection (trial version 6) [in Chinese].National Health Commission of the People's Republic of China website

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

COVID-19 in pregnancy: early lessons

Clinical features of patients infected with 2019 novel corona virus in Wuhan

Detection of 2019 novel corona virus (2019nCoV) by real-time RT-PCR

SUOG Interim Guidance on 2019 novel corona virus infection during pregnancy and puerperium: information for healthcare professionals

Corona virus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management

Relation Between Chest CT Findings and Clinical Conditions of Corona virus Disease (COVID-19) Pneumonia: A Multicenter Study

Correlation of chest CT and RT-PCR testing in corona virus disease 2019 (COVID-19) in China: a report of 1014 cases

Emerging understandings of 2019-nCoV

Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS)

A Case of 2019 Novel Corona virus in a Pregnant Woman With PretermDelivery

Novel corona virus disease (COVID-19) in pregnancy: What clinical recommendations to follow?

Remdesivir and chloroquine effectively inhibit the recently emerged novel corona virus (2019-nCoV)in vitro

Irwin Law, etal. Pharmacokinetics of chloroquine and monodesethyl chloroquine in pregnancy

Novel coronavirus technical guidance: patient management

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Obstetric considerations on delivery issues for pregnant women with COVID-19 infection

Novel corona virus infection and pregnancy

Corona virus disease 2019 (COVID-19) during pregnancy: a case series

Lung ultrasound and computed tomographic findings in pregnant woman with COVID-19

A case report of neonatal COVID-19 infection in China

Clinical analysis of pregnant women with 2019novel corona virus pneumonia

Mode of delivery and clinical findings in COVID-19 infected pregnant women in Northern Italy Powered by Editorial Manager and ProduXion Manager from Aries Systems Corporation

Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics (2020) Perinatal and neonatal management plan for prevention and control of 2019 novel corona virus infection

National Health Commission of the People's Republic of China